Many U.S. Adults Still Have Misconceptions About Skin Cancer Risk
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 26, 2025 -- About two-thirds of U.S. adults report no sunburns in the past year, with significant associations seen between the number of sunburns and sociodemographic factors, according to a study recently published online in the American Journal of Lifestyle Medicine.
Madison Etzel, from Florida Atlantic University in Boca Raton, and colleagues obtained information from the 2022 Health Information National Trends Survey 6 to explore sociodemographic characteristics, cancer risk perceptions, and behaviors surrounding sunburns. Associations between the number of sunburns and sociodemographic variables were examined. Data were included for 6,252 participants who were surveyed.
The researchers found that most respondents felt very confident or completely confident about their ability to take good care of their own health (44.0 and 27.3 percent, respectively). Most respondents were somewhat or slightly worried about getting cancer and few were extremely worried about getting cancer (28.3, 27.3, and 9.1 percent, respectively). Overall, 2.1, 30.3, and 67.6 percent reported experiencing more than six, one to five, and no sunburns, respectively, in the past 12 months. Significant associations were reported between the number of sunburns and age, gender, occupation status, marital status, education, Hispanic origin, race, and income level.
"Our study underscores the importance of raising awareness about skin cancer susceptibility as we found that all sociodemographic factors were significantly linked to the number of reported sunburns in the past year," Etzel said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-27 06:00
Read more

- Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
- Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
- Death Risk Doubled For ER Patients On Psychedelics
- U.S. Foreign Aid Cuts Could Devastate Global Progress Against HIV/AIDS
- Low Birth Weight Kids Lag In School Readiness
- Long-Term NSAID Use Linked to Reduced Dementia Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions